GenPath®, a division of BioReference, is a leading expert in cancer diagnostics, offering a comprehensive portfolio to support the continuum of care of cancer patients– from risk assessment to treatment planning. Backed by a team of specialized pathologists, GenPath delivers cutting-edge solutions that meet the unique needs of oncologists and pathologists, ranging from routine clinical and special coagulation to complex genomic testing for tumor sequencing and hereditary cancer syndromes.
GenPath® Oncology, a division of BioReference®, prides itself on being a leading provider of cutting-edge cancer diagnostics with industry-leading turnaround times. GenPath is backed by a team of specialized, board-certified pathologists and has experience in providing diagnostic oncology solutions to support the continuum of care of cancer patients, from routine clinical and special coagulation testing to complex genomic testing for tumor sequencing and hereditary cancer syndromes.